| 000 | 01789 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517062220.0 | ||
| 264 | 0 | _c20160811 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1179-1918 | ||
| 024 | 7 |
_a10.1007/s40261-015-0346-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKerwin, Edward M | |
| 245 | 0 | 0 |
_aPharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies. _h[electronic resource] |
| 260 |
_bClinical drug investigation _cJan 2016 |
||
| 300 |
_a55-65 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlbuterol _xadministration & dosage |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDry Powder Inhalers |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aForced Expiratory Volume |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocarbons, Fluorinated _xchemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetered Dose Inhalers |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRespiratory Function Tests |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aTaveras, Herminia | |
| 700 | 1 | _aIverson, Harald | |
| 700 | 1 | _aWayne, Denise | |
| 700 | 1 | _aShah, Tushar | |
| 700 | 1 | _aLepore, Mark S | |
| 700 | 1 | _aMiller, David S | |
| 773 | 0 |
_tClinical drug investigation _gvol. 36 _gno. 1 _gp. 55-65 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40261-015-0346-y _zAvailable from publisher's website |
| 999 |
_c25423285 _d25423285 |
||